| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/11/2012 | CN102311489A Plant heat-resistant gene BccDREB2A and application thereof |
| 01/11/2012 | CN102311484A Hexapeptide for inhabiting angiotensin transferase and preparation method thereof |
| 01/11/2012 | CN102309660A Traditional Chinese medicine (TCM) oral liquid containing sheep placenta and processing method thereof |
| 01/11/2012 | CN102309659A Traditional Chinese medicine (TCM) capsule containing sheep placenta and processing method thereof |
| 01/11/2012 | CN101824394B Streptococcus suis II-type subunit vaccine and application thereof |
| 01/11/2012 | CN101703155B Preparation method and application of prawn non-specific immunity reinforcing agent oligopeptide |
| 01/11/2012 | CN101550178B Blood polypeptide and preparation method and application thereof |
| 01/11/2012 | CN101225104B Method for preparing tilapia fishskin small molecular peptide chelate zinc salt |
| 01/11/2012 | CN101112222B Method for producing composite peptide hydrolysate, the rumen bypass composite peptide chelate complex and the production process thereof and the application |
| 01/10/2012 | US8093450 Non-aggregating fluorescent proteins and methods for using the same |
| 01/10/2012 | US8093362 p53 apoptosis effector related to PMP-22 (PERP) specific immunoglobulin for use in treatment and prevention of cell proliferative disorders |
| 01/10/2012 | US8093361 Anti-perp antibody |
| 01/10/2012 | US8093360 Antibodies that bind B. anthracis exotoxin, formulations thereof, and methods of use |
| 01/10/2012 | US8093359 Optimized Fc variants and methods for their generation |
| 01/10/2012 | US8093052 Serum-free culture medium for the production of recombinant gonadotropins |
| 01/10/2012 | US8093045 Nutrient broth for improving protein productivity in mammalian cell cultures |
| 01/10/2012 | US8093042 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 01/10/2012 | US8093036 Methods for producing hyaluronan in a recombinant host cell |
| 01/10/2012 | US8093029 Bilirubin oxidase mutant having thermal stability |
| 01/10/2012 | US8093019 Method for cellulase production |
| 01/10/2012 | US8093018 Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same |
| 01/10/2012 | US8093017 Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics |
| 01/10/2012 | US8093016 Use of an aspartic protease (NS24) signal sequence for heterologous protein expression |
| 01/10/2012 | US8092987 Mucosa tissue preserved with heating and hydrogen peroxide or phosphoric acid |
| 01/10/2012 | US8092798 Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8 |
| 01/10/2012 | US8092797 using monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 01/10/2012 | US8092794 Pharmaceutical compositions comprising SODs and prolamine based peptide fragments |
| 01/10/2012 | US8092531 Human skin equivalents expressing exogenous polypeptides |
| 01/10/2012 | CA2738176C Method for polyclonal immunoglobulin g production by human b cells |
| 01/10/2012 | CA2597701C Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype |
| 01/10/2012 | CA2528202C Process for recovering heterologous polypeptides from bacterial cells |
| 01/10/2012 | CA2455189C Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture |
| 01/10/2012 | CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/10/2012 | CA2400295C Modified factor viii |
| 01/10/2012 | CA2398726C High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 01/10/2012 | CA2388245C The use of serum-free adapted rat cells for producing heterologous polypeptides |
| 01/10/2012 | CA2262411C Resistance against nematodes and/or aphids |
| 01/10/2012 | CA2221342C A method and nucleotide sequence for transforming microorganisms |
| 01/05/2012 | WO2012001889A1 Cell capable of expressing tslp constantly and at high level, and method for screening for tslp modulator utilizing the cell |
| 01/05/2012 | WO2012000187A1 Fusion protein of g-csf variant, preparation method and use thereof |
| 01/05/2012 | WO2011143318A3 Anti-fgfr2 antibodies |
| 01/05/2012 | WO2011106723A3 Anti-paf antibodies |
| 01/05/2012 | WO2011096750A3 Method for preparing recombinant glycoproteins with high sialic acid content |
| 01/05/2012 | WO2011094593A3 Novel lowered affinity antibodies and methods of marking the same |
| 01/05/2012 | WO2002092832A9 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 01/05/2012 | US20120005782 Chemically inducible cucumber mosaic virus protein expression system |
| 01/05/2012 | US20120005777 Process for the Production of Fine Chemicals |
| 01/05/2012 | US20120005767 Antibodies to insulin-like growth factor i receptor |
| 01/05/2012 | US20120004398 Method for Uses of Protein Precursors as Prodrugs |
| 01/05/2012 | US20120004183 Unnatural reactive amino acid genetic code additions |
| 01/05/2012 | US20120004178 Biglycan mutants and related therapeutics and methods of use |
| 01/05/2012 | US20120003713 Polymerase Enhancing Factor (PEF) Extracts PEF Protein Complexes Isolated PEF Proteins and Methods for Purifying and Identifying |
| 01/05/2012 | US20120003697 High affinity antibodies to human il-6 receptor |
| 01/05/2012 | US20120003696 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids, monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 01/05/2012 | US20120003695 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris |
| 01/05/2012 | US20120003694 Bioengineered Protein Pores |
| 01/05/2012 | US20120003693 Novel peptide-forming enzyme gene |
| 01/05/2012 | US20120003692 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
| 01/05/2012 | US20120003691 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 01/05/2012 | US20120003675 Method for Preparing Small Volume Reaction Containers |
| 01/05/2012 | US20120003671 Methods for antibody engineering |
| 01/05/2012 | US20120003257 Recombinant avian infectious coryza vaccine and process for preparing same |
| 01/05/2012 | US20120003246 Novel composition and methods for the treatment of psoriasis |
| 01/05/2012 | US20120003235 Anti-lymphotoxin antibodies |
| 01/05/2012 | US20120003231 Cell surface molecule mediating cell adhesion and signal transmission |
| 01/05/2012 | US20120003211 Immunoglobulins with reduced aggregation |
| 01/05/2012 | US20120003210 NEONATAL Fc RECEPTOR (FcRn)- BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
| 01/04/2012 | EP2402439A1 Immunization method using cancer cell |
| 01/04/2012 | EP2402359A1 Recombinant protective protein from streptococcus pneumoniae |
| 01/04/2012 | EP2401378A2 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris |
| 01/04/2012 | EP2401365A1 Reengineering mrna primary structure for enhanced protein production |
| 01/04/2012 | EP2401289A1 Alteration and modulation of protein activity by varying post-translational modification |
| 01/04/2012 | EP2400984A1 Her2 antibody compositions |
| 01/04/2012 | EP2400981A1 Humanized platelet activating factor antibody design using anti-lipid antibody templates |
| 01/04/2012 | EP2059587B1 Laccases for pulp bio-bleaching |
| 01/04/2012 | EP1624847B1 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 01/04/2012 | EP1187850B1 Antimicrobial theta defensins and methods of using same |
| 01/04/2012 | CN1798838B Inhibitor proteins of a protease and use thereof |
| 01/04/2012 | CN102307485A System for production of ethanol and co-products |
| 01/04/2012 | CN102304556A Method for extracting mycobacterium tuberculosis antigens capable of stimulating two kinds of T cells simultaneously |
| 01/04/2012 | CN102304540A Expression equipment for expressing exogenous protein by secretion in trichoderma reesei and application of expression equipment |
| 01/04/2012 | CN102302768A Method for preparing brain protein hydrolysate oral liquid |
| 01/04/2012 | CN101864371B Homologous recombination construction double-GAL4 genotype industrial saccharomyces cerevisiae and application thereof |
| 01/04/2012 | CN101792738B Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof |
| 01/04/2012 | CN101607982B Fish skin collagen peptide with whitening effect and preparation process and application thereof |
| 01/04/2012 | CN101461939B Angiotensin converting enzyme inhibitor and preparation thereof |
| 01/04/2012 | CN101418330B Non protein culture medium adapted to large-scale culture of NSO cell and production of antibody |
| 01/04/2012 | CN101273134B Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes and method |
| 01/04/2012 | CN101087872B New mannoprotein with full solubility in wine and its application in the stabilisation of wine |
| 01/03/2012 | US8088972 Glyphosate-N-acetyltransferase (GAT) genes |
| 01/03/2012 | US8088896 Generation and profiling of fully human gold-derived therapeutic antibodies specific for human CD38 |
| 01/03/2012 | US8088893 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 01/03/2012 | US8088886 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/03/2012 | US8088736 CTLA-4 protein variants |
| 01/03/2012 | US8088617 Antibodies that bind the glutamate ligand binding region of Notch1 |
| 01/03/2012 | US8088613 Nitrilases, nucleic acids encoding them and methods for making and using them |
| 01/03/2012 | US8088601 Expression systems for functional membrane polypeptides |
| 01/03/2012 | US8088599 Nucleic acids encoding genetically modified tissue factor pathway inhibitor (TFPI) and method of making the same |
| 01/03/2012 | US8088598 Fungal transcriptional activator useful in methods for producing polypeptides |
| 01/03/2012 | US8088597 Peptide IPP is generated in high yields from preferably a small molecular weight protein having a high amount of -I-P-P- compared to -V-P-P- in its amino acid sequence; preferably the GMP fraction of kappa-casein is used; process comprises a single enzyme incubation step |